Research Articles | Page 81 | Aplastic Anemia and MDS International Foundation

Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journalsort descending Bone Marrow Disease
Increasing the effectiveness of hematopoiesis in myelodysplastic syndromes: erythropoiesis-stimulating agents and transforming growth factor-β superfamily inhibitors Sep 2017 Semin Hematol myelodysplastic syndromes (MDS)
Lenalidomide: Myelodysplastic syndromes with del(5q) and beyond Jun 2017 Semin Hematol
Optimizing the use of hypomethylating agents in myelodysplastic syndromes: Selecting the candidate, predicting the response, and enhancing the activity Jun 2017 Semin Hematol myelodysplastic syndromes (MDS)
Eltrombopag in aplastic anemia Jan 2015 Semin Hematol aplastic anemia
Increasing the effectiveness of hematopoiesis in myelodysplastic syndromes: erythropoiesis-stimulating agents and transforming growth factor-β superfamily inhibitors Jul 2017 Semin Hematol myelodysplastic syndromes (MDS)
Impaired proliferative potential of bone marrow mesenchymal stem cells in patients with myelodysplastic syndromes is associated with abnormal WNT signaling pathway Mar 2014 Stem Cells Dev myelodysplastic syndromes (MDS)
Azacitidine in the management of patients with myelodysplastic syndromes. Dec 2012 Ther Adv Hematol myelodysplastic syndromes (MDS)
Safety and efficacy of azacitidine in elderly patients with intermediate to high-risk myelodysplastic syndromes Jan 2017 Ther Adv Hematol myelodysplastic syndromes (MDS)
Management of thrombosis in paroxysmal nocturnal hemoglobinuria: a clinician's guide Mar 2017 Ther Adv Hematol paroxysmal nocturnal hemoglobinuria (PNH)
Eculizumab in the management of paroxysmal nocturnal hemoglobinuria: patient selection and special considerations Aug 2016 Ther Clin Risk Manag paroxysmal nocturnal hemoglobinuria (PNH)